Anitoa Systems to launch portable qPCR system

Maverick has been shown to detect only four copies pathogen molecule DNA per sample with over nine orders of magnitude in dynamic range.

Applications include near-patient diagnostics as well as food, agriculture and environment testing.

The firm has demonstrated the technology in detecting pathogen DNA and RNA strands such as Hepatitis B and C and E. coli.

Maverick is available now for evaluation through Anitoa's early access program (EAP) and commercial release is planned for Q3 2018.

Technology includes a proprietary low-light sensitive, complementary metal-oxide-semiconductor (CMOS) 4-channel fluorescence optics system that allows fast and multiplexed DNA detection without field calibration.

This replaces traditional photon-multiplier tube (PMT) and CCD-based optical sub-systems.

Maverick has a cloud-based software connected to the Internet and enables cloud data storage and retrieval.

Dr Zhimin Ding, CEO of Anitoa Systems, said the portable qPCR device has performance that rivals lab-based systems.

"We strive to make our molecular testing systems rugged, accessible, and with battery operation and power-loss protection capability to facilitate their effective use in low resource settings."​